Journal: Nucleic Acids Research
Article Title: BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A
doi: 10.1093/nar/gkae605
Figure Lengend Snippet: BOD1L loss decreases SETD1A on chromatin. ( A ) Browser view of ChIP-seq results against SETD1A, NELFE, RNAP2 NTD, Ser5P, Ser2P, H3K4me3 and H3K36me3 at INTS2 loci in sgBOD1L-expressing leukemia cells. ( B ) Average ChIP-seq signals of SETD1A, NELFE, NTD and Ser5P along DR (SETD1A-target) genes and flanking regions from sgAAVS and sgBOD1L-expressing cells are shown. ( C ) Violin plot indicating signal intensity of SETD1A at DR genes. ( D ) Pausing index (Log 2 ) of all genes and BOD1L/SETD1A targets. ( E ) Browser view of ChIP-seq results against SETD1A and BOD1L (top); 8307 peaks were overlapped (bottom). ( F ) Distributions of SETD1A, NTD and Ser5P at 9290 peaks ± 2kb harboring BOD1L binding 1 h after BOD1L degradation. Violin plot indicating signal intensities of each peak. ( G ) Distributions and signal intensities of H3K4me3 at BOD1L-binding regions 24 h after BOD1L degradation. In (C), (D), (F) and (G), data are presented as mean ± SD. ** P < 0.01. * P < 0.05. ns, no significance.
Article Snippet: Primary antibodies against HA-tag (#3724, Cell Signaling), SETD1A (#61702, Cell Signaling), RNAP2-NTD (#14958, Cell Signaling), RNAP2-Ser5P (#13523, Cell Signaling), RNAP2-Ser2P (#13499, Cell Signaling), NELFE (#ab170104, Abcam), H3K4me3 (#ab8580, Abcam), H3K36me3 (#9050, Abcam), RPA2 (#ab10359, Abcam), and RBBP5 (A300-109A, Bethyl Laboratories) were used.
Techniques: ChIP-sequencing, Expressing, Binding Assay